No Data
No Data
Mind Medicine Is Maintained at Buy by Roth MKM
Mind Medicine Price Target Maintained With a $36.00/Share by Roth MKM
Roth MKM Maintains Buy on Mind Medicine, Maintains $36 Price Target
Roth MKM Initiates Mind Medicine(MNMD.US) With Buy Rating, Announces Target Price $36
Roth MKM analyst Jason Wittes initiates coverage on $Mind Medicine(MNMD.US)$ with a buy rating, and sets the target price at $36.According to TipRanks data, the analyst has a success rate of 52.8%
Mind Medicine Says New Patent Secured for Investigational Anxiety Disorder Treatment MM120
Express News | MindMed Announces Issuance of New Patent for Mm120 Orally Disintegrating Tablet (Odt)
No Data